Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Tamás Erdei"'
Autor:
Zoltán Karácsonyi, Tamás Erdei
Publikováno v:
Egészségügyi Innovációs Szemle. 2:35-47
A klinikai gyógyszerészet a XX. század végén fejlődött ki az Amerikai Egyesült Államokban, melynek nem titkolt célja a gyógyszerész szakma szerepkörének a bővítése, valamint a betegspecifikus gyógyszeres terápia optimalizációja.
Autor:
Ignác Óvári, Viktória Szilágyi, Gábor Viczján, Nóra Lampé, Miklós Bege, Anikó Borbás, Pál Herczeg, Béla Juhász, Rudolf Gesztelyi, Tamás Erdei
Publikováno v:
Egészségügyi Innovációs Szemle. 1
A hipoxantin-triciklánó egy a DE GYTK Gyógyszerészi Kémia Tanszéken szintetizált adenozin analóg, melyben az adenint hipoxantin, a ribózt pedig egy kondenzált triciklikus molekularész helyettesíti. Munkánk során a hipoxantin-triciklán
Autor:
Angela Mikaczo, Csaba Papp, Tamas Erdei, Aniko Posa, Gabor Zahuczky, Csaba Varga, Janos Szabo, Rudolf Gesztelyi, Maria Szilasi, Judit Zsuga
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Albeit smoking cessation has unequivocal health benefits, attempts to quit are not unanimous, even in patient populations at high risk for smoking-related diseases cessation. Allelic variations of enzymes involved in dopamine meta
Externí odkaz:
https://doaj.org/article/c0a2ae03fba8402d8bff37013d554321
Publikováno v:
Porta Lingua. :77-86
There has been a growing research interest into the implementation of Content and Language Integrated Learning (CLIL) in higher education, however, limited research attention has been devoted to the investigation of the situation in the Visegrad coun
Autor:
Nóra Lampé, Dániel Priksz, Tamás Erdei, Mariann Bombicz, Rita Kiss, Balázs Varga, Judit Zsuga, Tamás Szerafin, Zoltán Csanádi, György Balla, József Balla, Zoltán Szilvássy, Rudolf Gesztelyi, Béla Juhász
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 1434, p 1434 (2020)
Journal of Clinical Medicine, Vol 9, Iss 1434, p 1434 (2020)
Cardiovascular morbidity and mortality carry great socioeconomic burden worldwide that mandates the development of new, efficacious therapeutic agents with limited adverse effects. O-(3-piperidino-2-hydroxy-1-propyl) nicotinic acid amidoxime (BGP-15)
Autor:
Ignac Ovari, Gabor Viczjan, Tamas Erdei, Barbara Takacs, Vera Tarjanyi, Judit Zsuga, Miklos Szucs, Zoltan Szilvassy, Bela Juhasz, Rudolf Gesztelyi
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
The receptorial responsiveness method (RRM) enables the estimation of a change in concentration of an (even degradable) agonist, near its receptor, via curve fitting to (at least) two concentration-effect (E/c) curves of a stable agonist. One curve s
Externí odkaz:
https://doaj.org/article/972b6fd40489411ea1af45c47d01b30c
Publikováno v:
Acta pharmaceutica Hungarica. 84(1)
Cardiovascular disease is the biggest challenge in terms of life expectancy in developed countries. Adenosine contributes to the adaptation of the heart to ischemia and hypoxia, because adenosine, in addition to its metabolite role in the nucleic aci
Autor:
Gabor Viczjan, Anna Szilagyi, Barbara Takacs, Ignac Ovari, Reka Szekeres, Vera Tarjanyi, Tamas Erdei, Vanda Teleki, Judit Zsuga, Zoltan Szilvassy, Bela Juhasz, Balazs Varga, Rudolf Gesztelyi
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Cannabidiol (CBD), the most extensively studied non-intoxicating phytocannabinoid, has been attracting a lot of interest worldwide owing to its numerous beneficial effects. The aim of this study was to explore the effect that CBD exerts on the adenos
Externí odkaz:
https://doaj.org/article/bcba8b436b4d4d11859545dfaf32956f
Autor:
Olivier Huttin, Alan G. Fraser, Lars H. Lund, Erwan Donal, Cecilia Linde, Masatake Kobayashi, Tamas Erdei, Jean‐Loup Machu, Kevin Duarte, Patrick Rossignol, Walter Paulus, Faiez Zannad, Nicolas Girerd, MEDIA and KaRen investigators
Publikováno v:
ESC Heart Failure, Vol 8, Iss 3, Pp 1827-1839 (2021)
Abstract Aims Echocardiographic predictors of outcomes in heart failure with preserved ejection fraction (HFpEF) have not been systematically or independently validated. We aimed at identifying echocardiographic predictors of cardiovascular events in
Externí odkaz:
https://doaj.org/article/ea24e683edf14a03ab8bb247b79db2c0
Autor:
Tamás Erdei, Attila Kardos, Csaba Földesi, Mónika Dénes, Maria Lengyel, András Temesvári, Attila Mihálcz
Publikováno v:
Cardiovascular Ultrasound
Cardiovascular Ultrasound, Vol 10, Iss 1, p 11 (2012)
Cardiovascular Ultrasound, Vol 10, Iss 1, p 11 (2012)
Background Radiofrequency catheter ablation of atrial fibrillation (AF) has been proved to be effective and to prevent progressive left atrial (LA) remodeling. Cryoballoon catheter ablation (CCA), using a different energy source, was developed to sim